Metraipolis › archive › dc_4cdecf93ca56

Long-term oral glucocorticoid use is associated with complications, healthcare resource utilization, and costs among patients with dermatomyositis or… — Europe PMC PMID:40926183

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40926183
DOI: 10.1007/s10067-[numero omesso]-1
License (as archived): solo-consultazione
Archived: 2026-10-08T14:48:24.106Z
SHA-256 of the archived text: 06f963626ec1167e1563087b1dffb175f465f7738d969a6b23f5a1cd70f26c32
Stable URL of this page: https://metraipolis.com/documento/dc_4cdecf93ca56

How to cite

Long-term oral glucocorticoid use is associated with complications, healthcare resource utilization, and costs among patients with dermatomyositis or… — Europe PMC PMID:40926183 — Europe PMC (en), https://europepmc.org/article/MED/40926183 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cdecf93ca56 (Metraipolis archive dc_4cdecf93ca56, sha256 06f963626ec1167e1563087b1dffb175f465f7738d969a6b23f5a1cd70f26c32)

BibTeX

@misc{dc4cdecf93ca56,
  title = {Long-term oral glucocorticoid use is associated with complications, healthcare resource utilization, and costs among patients with dermatomyositis or… — Europe PMC PMID:40926183},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40926183},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cdecf93ca56; sha256 06f963626ec1167e1563087b1dffb175f465f7738d969a6b23f5a1cd70f26c32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40926183. Agents can read the archived copy with the MCP tool read_document.